We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

158 hedge funds and large institutions have $344M invested in Maravai LifeSciences in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $1.29M | Put options by funds: $1.08M

17% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 24

1% less funds holding

Funds holding: 159 → 158 (-1)

2% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 52

6.28% less ownership

Funds ownership: 89.23% → 82.95% (-6.3%)

18% less capital invested

Capital invested by funds: $421M → $344M (-$77.2M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
158
Holders Change
-1
Holders Change %
-0.63%
% of All Funds
1.94%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
28
Increased
51
Reduced
52
Closed
24
Calls
$1.29M
Puts
$1.08M
Net Calls
+$207K
Net Calls Change
-$3.15M

Top Buyers

1
B
Braidwell
Connecticut
+$6.4M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.94M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2.49M
4
First Eagle Investment Management
First Eagle Investment Management
New York
+$2.46M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.89M

Top Sellers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$18.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.67M
3
MFS
Mirabella Financial Services
United Kingdom
-$6.86M
4
1WCM
12 West Capital Management
New York
-$5.63M
5
EP
Eversept Partners
New York
-$2.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
151
SBI Securities
Japan
$880 – – –
PA
152
Parallel Advisors
California
$761 -$11.9K -3,516 -93%
CPBTD
153
Central Pacific Bank - Trust Division
Hawaii
$665 – – –
MEG
154
Millstone Evans Group
Colorado
$458 – – –
SFS
155
Sunrise Financial Services
Washington
$187 +$224 +66 New
TFA
156
Transamerica Financial Advisors
Florida
$67 – – –
EP
157
Essential Partners
California
$45 +$54 +16 New
RFP
158
Root Financial Partners
California
$37 +$44 +13 New
Wellington Management Group
159
Wellington Management Group
Massachusetts
– -$7.67M -2,360,059 Closed
MFS
160
Mirabella Financial Services
United Kingdom
– -$6.86M -2,110,545 Closed
Two Sigma Advisers
161
Two Sigma Advisers
New York
– -$2.85M -876,700 Closed
EP
162
Eversept Partners
New York
– -$2.34M -718,582 Closed
MCM
163
Massar Capital Management
Connecticut
– -$650K -200,000 Closed
CAU
164
Caxton Associates (UK)
– -$490K -150,751 Closed
TD Asset Management
165
TD Asset Management
Ontario, Canada
– -$474K -145,984 Closed
ICM
166
Irenic Capital Management
New York
– -$262K -80,668 Closed
DekaBank Deutsche Girozentrale
167
DekaBank Deutsche Girozentrale
Germany
– -$411K -44,000 Closed
ACM
168
Aquatic Capital Management
Illinois
– -$135K -41,457 Closed
TSS
169
Two Sigma Securities
New York
– -$70.2K -21,614 Closed
HT
170
Headlands Technologies
Illinois
– -$65.9K -20,272 Closed
CFO
171
Callan Family Office
Pennsylvania
– -$47.1K -14,485 Closed
JG
172
Jain Global
New York
– -$36.5K -11,216 Closed
IAS
173
Insigneo Advisory Services
Florida
– -$34.4K -10,574 Closed
VF
174
Virtu Financial
New York
– -$34K -10,309 Closed
A
175
AlphaQuest
New York
– -$13.6K -4,177 Closed
4 5 6
7
8

MRVI Hedge Fund Activity: Q1 2026 in Review

158 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q1 2026, worth a combined $344M — down 18% from $421M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new MRVI positions and 24 closed out — a net gain of 4 holders — while 51 added to existing stakes and 52 trimmed.

The largest buyer was Braidwell, adding an estimated $6.4M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $18.1M.

  • 158 institutional investors held Maravai LifeSciences (MRVI) as of Q1 2026, down from 159 in Q4 2025.
  • Funds reported $344M of Maravai LifeSciences stock for Q1 2026, down 18% quarter-over-quarter.
  • 28 funds opened new Maravai LifeSciences positions in Q1 2026 and 24 closed out, a net change of +4 holders.
  • The largest Maravai LifeSciences buyer in Q1 2026 was Braidwell, an estimated $6.4M added.
  • The largest Maravai LifeSciences seller in Q1 2026 was T. Rowe Price Investment Management, an estimated $18.1M sold.

Based on aggregated 13F filings for Q1 2026.